Heparin-Linked Deaths

June 2008
Critical Care Nurse;Jun2008, Vol. 28 Issue 3, p11
Academic Journal
The article reports on deaths associated with heparin in the U.S. Baxter Healthcare Corp. recalled all its products from the market with heparin because of reported deaths and adverse reactions linked with the use of heparin. The U.S. Food & Drug Administration (FDA) stated that the contamination with heparin was likely because of the economy.


Related Articles

  • Heparin mystery so far resistant to the best efforts of CDC, FDA. McCarty, Mark // Medical Device Daily;2/13/2008, Vol. 12 Issue 30, p3 

    This article reports on the efforts of the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention to determine the source of the problem that led to the recall of heparin sodium for injection by Baxter Healthcare. Pending the outcome of the investigation into...

  • FDA officials admit they inspected wrong heparin plant. Tanne, Janice Hopkins // BMJ: British Medical Journal (International Edition);2/23/2008, Vol. 336 Issue 7641, p412 

    The article focuses on a public statement which was issued by the U.S. Food and Drug Administration. In the statement the administration indicated that it inspected the wrong heparin plant when investigating a recall of multidose vials of heparin which was linked to four deaths and 350 reports...

  • Baxter recalls remaining lots and doses of heparin sodium vials. Adams, Stacey L. // Infectious Disease News;Mar2008, Vol. 21 Issue 3, p43 

    The article reports on the decision of Baxter Healthcare Corp. to voluntarily recall its remaining batch of heparin sodium injection multi-dose, single-dose vials and HEP-LOCK heparin flush products on February 28, 2008. Due to a lack of suppliers, the U.S. Food and Drug Administration (FDA) did...

  • Bad Medicine From China Increases Safety Concerns. Alaimo, Dan // SN: Supermarket News;3/3/2008, Vol. 56 Issue 9, p12 

    The article reports on safety issues surrounding Chinese medicines. The U.S. Food and Drug Administration found out that the blood thinner heparin, made by Baxter Healthcare Corp., has been linked to serious allergic reactions. The problem apparently stems from a Chinese plant that supplies most...

  • FDA U.S FOOD & DRUG ADMINISTRATION UPDATE.  // Materials Management in Health Care;Apr2009, Vol. 18 Issue 4, p5 

    The article offers news briefs related to pharmaceutical industry in the U.S. The Food and Drug Administration (FDA) approved the use of SyntheMed Inc.'s Repel-CV adhesion barrier for use in pediatric cardio-surgery patients. Sedecal S.A. got the FDA approval of its X-Plus LP stationary digital...

  • FDA orders Baxter to recall infusion pumps.  // Hospice Management Advisor;Jun2010, Vol. 15 Issue 6, p66 

    The article reports on the letter sent by the U.S. Food and Drug Administration (FDA) to Baxter Healthcare Corp. on April 30, 2010. It says that the letter orders Baxter to recall and ruin all its Colleague Volumetric Infusion Pumps, which is in use in the U.S, give refunds to the customers, and...

  • FDA says recall of Baxter's infusion pump now class I.  // Medical Device Daily;3/13/2009, Vol. 13 Issue 48, p2 

    The article reports on the decision of the U.S. Food and Drug Administration (FDA) to elevate the recall of the Colleague line of infusion pumps made by Baxter Healthcare to a class I recall. A statement was issued by the company claiming that safe and effective use of Colleague pumps is...

  • Baxter faces yet another Class I recall for pumps.  // Medical Technology & Devices Week;7/30/2007, Vol. 5 Issue 31, p5 

    The article reports on the announcement by Baxter Healthcare that the U.S. Food and Drug Administration has classified another recall of its Colleague and Flo-Gard infusion pumps as the serious, Class I variety. The company said the most recent recall is voluntary and pertaining to 534 infusion...

  • Hospitals urged to monitor Baxter infusion pumps. Sipkoff, Martin // Drug Topics;10/24/2005, Vol. 149 Issue 20, Special section p28 

    This article reports that Baxter Healthcare Corp. has received a second Food and Drug Administration Class 1 recall for its Colleague Volumetric Infusion Pumps in the U.S. Recalls relates to pump battery excessive discharge and swelling failures, which cause the devices to become incapable of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics